Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology

被引:133
作者
Blagg, Julian [1 ]
Workman, Paul [1 ]
机构
[1] Inst Canc Res, Canc Res UK Canc Therapeut Unit, Sutton SM2 5NG, Surrey, England
关键词
ASSAY INTERFERENCE COMPOUNDS; SMALL-MOLECULE; DRUG DISCOVERY; IN-VITRO; KINASE INHIBITORS; PROTEIN-KINASE; MEDICINAL CHEMISTRY; TARGET VALIDATION; DRUGGABLE GENOME; BET BROMODOMAINS;
D O I
10.1016/j.ccell.2017.06.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Small-molecule chemical probes or tools have become progressively more important in recent years as valuable reagents to investigate fundamental biological mechanisms and processes causing disease, including cancer. Chemical probes have also achieved greater prominence alongside complementary biological reagents for target validation in drug discovery. However, there is evidence of widespread continuing misuse and promulgation of poor-quality and insufficiently selective chemical probes, perpetuating a worrisome and misleading pollution of the scientific literature. We discuss current challenges with the selection and use of chemical probes, and suggest how biologists can and should be more discriminating in the probes they employ.
引用
收藏
页码:9 / 25
页数:17
相关论文
共 127 条
  • [21] Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
    Bowes, Joanne
    Brown, Andrew J.
    Hamon, Jacques
    Jarolimek, Wolfgang
    Sridhar, Arun
    Waldron, Gareth
    Whitebread, Steven
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (12) : 909 - 922
  • [22] Rules for Identifying Potentially Reactive or Promiscuous Compounds
    Bruns, Robert F.
    Watson, Ian A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 9763 - 9772
  • [23] Target validation using chemical probes
    Bunnage, Mark E.
    Chekler, Eugene L. Piatnitski
    Jones, Lyn H.
    [J]. NATURE CHEMICAL BIOLOGY, 2013, 9 (04) : 195 - 199
  • [24] Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS
    Capuzzi, Stephen J.
    Muratov, Eugene N.
    Tropsha, Alexander
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2017, 57 (03) : 417 - 427
  • [25] Characterization of the 4-(Benzothiazol-2-yl)phenylnitrenium Ion from a Putative Metabolite of a Model Antitumor Drug
    Chakraborty, Mrinal
    Jin, Kyoung Joo
    Glover, Stephen A.
    Novak, Michael
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 2010, 75 (15) : 5296 - 5304
  • [26] Chemical Probes Portal, 2017, HIST COMP
  • [27] Chemical Probes Portal, 2017, PORT NEWS RIG EV CHE
  • [28] On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
    Cho, Hyejin
    Du, Xinlin
    Rizzi, James P.
    Liberzon, Ella
    Chakraborty, Abhishek A.
    Gao, Wenhua
    Carvo, Ingrid
    Signoretti, Sabina
    Bruick, Richard K.
    Josey, John A.
    Wallace, Eli M.
    Kaelin, William G., Jr.
    [J]. NATURE, 2016, 539 (7627) : 107 - +
  • [29] Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
    Ciceri, Pietro
    Mueller, Susanne
    O'Mahony, Alison
    Fedorov, Oleg
    Filippakopoulos, Panagis
    Hunt, Jeremy P.
    Lasater, Elisabeth A.
    Pallares, Gabriel
    Picaud, Sarah
    Wells, Christopher
    Martin, Sarah
    Wodicka, Lisa M.
    Shah, Neil P.
    Treiber, Daniel K.
    Knapp, Stefan
    [J]. NATURE CHEMICAL BIOLOGY, 2014, 10 (04) : 305 - +
  • [30] NIH plans to enhance reproducibility
    Collins, Francis S.
    Tabak, Lawrence A.
    [J]. NATURE, 2014, 505 (7485) : 612 - 613